Dementia - Articles - Page 3 | CARLAT PUBLISHING

Annual Flu Vaccines

July 1, 2022

Thomas Jordan, MD. Dr. Jordan, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Although there is an association between influenza vaccinations and a lower dementia risk, association is not causation.

Assessing and Treating Delirium in Older Adults

July 1, 2022

Rehan Aziz, MD.

Rehan Aziz, MD. Associate program director, Geriatric Psychiatry Fellowship Program, Jersey Shore University Medical Center; associate professor of psychiatry and behavioral science, Hackensack Meridian School of Medicine, Edison, NJ. Dr. Aziz, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Treatment of delirium involves correction of the underlying medical disturbance. But how do we best think through potential causes? Dr. Aziz shares his systematic approach and clinical pearls in conducting a physical exam and ordering the appropriate work-up.

CLINICAL UPDATE

The 3 Ds of Geriatric Psychiatry: Depression, Delirium, and Dementia

July 1, 2022

Rachel Meyen, MD

Rachel Meyen, MD. Outpatient geriatric psychiatrist, General Mental Health Clinic, Sacramento VA Medical Center, Mather, CA. Dr. Meyen, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Symptoms of dementia, delirium, and depression in older adults may overlap, and these disorders often occur simultaneously. We learn how to disentangle these three illnesses through screeners and medical work-up, and how to optimize their management.

How to Interview the Older Patient

January 1, 2022

Rehan Aziz, MD. Inpatient geriatric psychiatry, Hackensack-Meridian Health, Perth Amboy, NJ. Dr. Aziz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The expanding population of older adults has created a need for all clinicians to participate in their care. Interviewing techniques require adaptation in older adults, such as accounting for hearing or vision impairment and speaking slowly and clearly. This article will cover additional factors to consider when evaluating older patients.

In the News: Aducanumab (Aduhelm)

November 5, 2021

Rehan Aziz, MD.

Rehan Aziz, MD. Associate professor of psychiatry and neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

When the FDA approved aducanumab (Aduhelm) in Alzheimer dementia, the decision came with a heavy dose of controversy. Rehaz Aziz, MD, considers where this novel therapy fits in practice.

In Brief: Meds in the Fast Lane

November 5, 2021

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC.

In the last five years, more psychotropics have gained approval through the FDA’s expedited pathways than the slow and cautious routes we’ve grown used to. These “fast-track” and “breakthrough therapy” approvals allow drugs to enter the market on the basis of more efficient (ie, smaller) clinical trials.

Q&A

Treating Agitation in Patients with Dementia

September 13, 2021

Eran Metzger, MD

Eran Metzger, MD

Medical Director of Psychiatry, Hebrew SeniorLife, Boston, MA. Assistant Professor of Psychiatry, Harvard Medical School, Boston, MA.

Dr. Metzger has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The behavioral and psychological symptoms of dementia can be challenging to manage. Dr. Metzger discusses his approach in the diagnosis and treatment of agitated patients with dementia.

Anticholinergic Drugs and Risk of Cognitive Impairment and Dementia

September 13, 2021

Shelly L. Gray, PharmD

Shelly L. Gray, PharmD

Professor and Plein Endowed Director, Plein Center for Geriatric Pharmacy Research, School of Pharmacy, University of Washington, Seattle, WA.

Dr. Gray has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Might anticholinergic medications increase the risk of long-term cognitive impairment? Dr. Gray reviews the data.

Note From the Editor-in-Chief

September 13, 2021

Victoria Hendrick, MD. Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center. Dr. Hendrick has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Sometimes we have little choice but to administer sedating medications to a combative patient who is putting others at risk of injury. Which medications work most quickly, safely, and effectively?

Rest Easy: Benzos, Z-Drugs, and Dementia

December 31, 2020

James Jenkins, MD.

James Jenkins, MD. Dr. Jenkins has disclosed that he has stock in Alkermes, Sage Therapeutics, Teva Pharmaceutical Industries, Trevena, and Viatris. Dr. Aiken has reviewed this article and has found no evidence of bias pertaining to this educational activity.

It may not be perfect, but this study has the best data yet on the controversial link between benzodiazepines and dementia.